 |
| |
Last week's decision of UBM Canon to cease production of its remaining brands in the pharma BtoB suite marks a transition for our industry. All of us benefited from the diversity and range of titles as well as the competitive opportunities to provide the best perspectives on the issues that defined our collective audience demographic. I wish our colleagues at MedAd News, Pharmalot, eKnowledge Base and R&D Directions the best in their future endeavors.
But for those of us that remain in this vertical, there is an equal obligation to stay relevant to you, our advertisers and content partners. That obligation begins by informing you that Pharmaceutical Executive will continue to provide our audience of over 95,000 worldwide decision-makers the same high standards of editorial integrity and quality that they have come to expect over the past 30+ years. Our staff leads the BtoB segment in awards won for editorial excellence, which over the years has meant only one thing: advertisers in Pharmaceutical Executive profit from the connections they make through us.
And with the current disarray in the roll out of national health care reform, our joint editorial
mission – to help pharma make that connection "where business meets policy" – has never been more relevant.
The Pharmaceutical Executive brand provides you with the largest worldwide audience of over 95,000 (unduplicated) biopharmaceutical executives. We address the needs of our audience with the analysis of business, strategy and government regulations that no one else provides. We go beyond the news and provide in-depth analysis to help executives navigate through the maze of policy and business challenges that face this industry. Your thought leadership or brand message in Pharmaceutical Executive will be surrounded by the content that your customers cannot get elsewhere.
Pharmaceutical Executive provides this information through the review of the issues, interviews and roundtable discussions with thought leaders and pharma leaders. You can take advantage of this engaging content in a number of different platforms; print, online, webinars, white papers, video, newsletters and face-to-face conferences.
Pharmaceutical Executive has been addressing the informational needs of the c-suite and those aspiring to the join the c-suite for over 30 years. We are unique in our approach of providing engaging editorial content and an approach that no one else provides.
If you would like to reach our 95,000 pharma executives, give one our team members a call.
Happy holidays,
Russ Pratt
VP/Group Publisher |
|
|
 |
|